Atlantic Edge Private Wealth Management, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 2011145
JACKSONVILLE, FL
Position in VRTX
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$62,091
+$6,274 QoQ
Shares Held
125
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#481
of 593 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Atlantic Edge Private Wealth Management, LLC holds $2,626,595 across 7 Biotechnology names. VRTX ranks #3 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
14,535 | $1,647,687 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,449 | $903,509 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
125 | $62,091 | |
| 4 | DFTX |
Definium Therapeutics, Inc.
|
193 | $9,078 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
10 | $1,872 | |
| 6 | PCVX |
Vaxcyte, Inc.
|
25 | $1,453 | |
| 7 | HELP |
Cybin Inc.
|
137 | $905 |
All Filings in VRTX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $62,091 | 125 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $55,817 | 125 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $56,670 | 125 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $48,955 | 125 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $55,650 | 125 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $60,602 | 125 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $32,216 | 80 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $37,206 | 80 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $35,154 | 75 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $31,350 | 75 | Shares | Sole | 2024-05-08 | |
| No filing history on record for this holder in this stock. | ||||||